| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.
|
Cell
|
2001
|
11.99
|
|
2
|
Does exposure to hyperglycaemia in utero increase the risk of obesity and diabetes in the offspring? A critical reappraisal.
|
Diabet Med
|
2014
|
2.79
|
|
3
|
Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post-menopausal women.
|
Clin Endocrinol (Oxf)
|
1996
|
2.05
|
|
4
|
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial.
|
Am J Med
|
1996
|
2.00
|
|
5
|
Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment.
|
J Med Genet
|
2005
|
1.69
|
|
6
|
Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?
|
Br Med J
|
1978
|
1.49
|
|
7
|
Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responses.
|
Q J Med
|
1979
|
1.32
|
|
8
|
Increasing prevalence of type 2 diabetes in adolescents.
|
J Paediatr Child Health
|
2004
|
1.28
|
|
9
|
Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes.
|
Diabet Med
|
2002
|
1.16
|
|
10
|
Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35.
|
Am J Hum Genet
|
2001
|
1.14
|
|
11
|
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
|
J Clin Invest
|
2000
|
1.09
|
|
12
|
1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
|
J Bone Miner Res
|
2000
|
1.09
|
|
13
|
Osteomalacia after pamidronate for Paget's disease.
|
Lancet
|
1994
|
1.07
|
|
14
|
Ciguatera fish poisoning: a double-blind randomized trial of mannitol therapy.
|
Neurology
|
2002
|
1.04
|
|
15
|
Familial Paget's disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q.
|
Bone
|
2000
|
1.04
|
|
16
|
Referrals to psychiatrists in a general hospital--comparison of two methods of liaison psychiatry: preliminary communication.
|
J R Soc Med
|
1985
|
1.00
|
|
17
|
Possible function of different renal metabolites of vitamin D in man.
|
Contrib Nephrol
|
1980
|
1.00
|
|
18
|
Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone.
|
Exp Hematol
|
1999
|
1.00
|
|
19
|
Lifetime risk of symptomatic carpal tunnel syndrome in Type 1 diabetes.
|
Diabet Med
|
2005
|
0.98
|
|
20
|
The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment.
|
J Inherit Metab Dis
|
2002
|
0.97
|
|
21
|
A population-based study of bone mineral density in women with longstanding type 1 (insulin dependent) diabetes.
|
Diabetes Res Clin Pract
|
1998
|
0.96
|
|
22
|
Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors.
|
Osteoporos Int
|
2011
|
0.96
|
|
23
|
Paget's disease in New Zealand: evidence for declining prevalence.
|
Bone
|
2002
|
0.96
|
|
24
|
Osteoporosis pseudoglioma syndrome: treatment of spinal osteoporosis with intravenous bisphosphonates.
|
J Pediatr
|
2000
|
0.95
|
|
25
|
Paget's disease of bone in New Zealand: continued decline in disease severity.
|
Calcif Tissue Int
|
2004
|
0.91
|
|
26
|
The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
|
Clin Endocrinol (Oxf)
|
1998
|
0.89
|
|
27
|
Severe intrauterine growth retardation and atypical diabetes associated with a translocation breakpoint disrupting regulation of the insulin-like growth factor 2 gene.
|
J Clin Endocrinol Metab
|
2008
|
0.87
|
|
28
|
Responses to salmon calcitonin in chronic renal failure: relation to histological and biochemical indices of bone turnover.
|
Eur J Clin Invest
|
1981
|
0.87
|
|
29
|
Who gets renal bone disease before beginning dialysis?
|
Br Med J (Clin Res Ed)
|
1985
|
0.86
|
|
30
|
Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.
|
Br Med J (Clin Res Ed)
|
1982
|
0.86
|
|
31
|
Screening for diabetes during pregnancy.
|
BMJ
|
1993
|
0.85
|
|
32
|
Plasma hydroxyproline in uremia: relationships with histologic and biological indices of bone turnover.
|
Metab Bone Dis Relat Res
|
1983
|
0.85
|
|
33
|
Effects of vitamin D metabolites and analogues on renal function.
|
Nephron
|
1981
|
0.85
|
|
34
|
Calcium homoeostasis during pregnancy.
|
Br Med J (Clin Res Ed)
|
1981
|
0.85
|
|
35
|
Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.
|
Rheumatology (Oxford)
|
2005
|
0.84
|
|
36
|
Calcium metabolism and hyperparathyroidism after renal transplantation.
|
Q J Med
|
1983
|
0.83
|
|
37
|
Differences in hip axis and femoral neck length in premenopausal women of Polynesian, Asian and European origin.
|
Osteoporos Int
|
1997
|
0.82
|
|
38
|
Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption.
|
Bone
|
1987
|
0.81
|
|
39
|
Evidence for a major gene for bone mineral density in idiopathic osteoporotic families.
|
J Bone Miner Res
|
2000
|
0.80
|
|
40
|
An estimate of the endogenous secretion rate of calcitonin in man.
|
Clin Sci (Lond)
|
1982
|
0.79
|
|
41
|
Clostridium difficile and non-antibiotic-associated colitis.
|
Lancet
|
1980
|
0.79
|
|
42
|
Depot medroxyprogesterone acetate in teens: A risk for bone health?
|
Pediatrics
|
2000
|
0.79
|
|
43
|
Longer femoral necks in the young: a predictor of further increases in hip fracture incidence?
|
N Z Med J
|
1996
|
0.78
|
|
44
|
The relationship between disturbed metabolism of vitamin D and bone disease in chronic renal failure.
|
Proc Eur Dial Transplant Assoc
|
1979
|
0.78
|
|
45
|
Fetal liver length in diabetic pregnancy.
|
Am J Obstet Gynecol
|
1994
|
0.77
|
|
46
|
Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
|
J Clin Lab Immunol
|
1989
|
0.77
|
|
47
|
Glomerular hyperfiltration in young Polynesians with type 2 diabetes.
|
Diabetes Res Clin Pract
|
1994
|
0.77
|
|
48
|
Physiological and pharmacological aspects of 24,25-dihydroxycholecalciferol in man.
|
Adv Exp Med Biol
|
1978
|
0.77
|
|
49
|
Reversible severe deterioration of glycaemic control after withdrawal of metformin treatment.
|
Diabetologia
|
2011
|
0.77
|
|
50
|
Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus.
|
Aust N Z J Med
|
1994
|
0.76
|
|
51
|
Bone loss and depot medroxyprogesterone.
|
Am J Obstet Gynecol
|
1997
|
0.76
|
|
52
|
Efficacy of peritoneal dialysis in severe thiazide-induced hyponatraemia.
|
Postgrad Med J
|
1981
|
0.76
|
|
53
|
Deterioration of renal bone disease in patients treated with salmon calcitonin.
|
Clin Endocrinol (Oxf)
|
1982
|
0.76
|
|
54
|
Prediction of albumin excretion rate from albumin-to-creatinine ratio.
|
Diabetes Care
|
2000
|
0.75
|
|
55
|
Do all women require intensive retinal surveillance during pregnancy?
|
Diabetes Care
|
2001
|
0.75
|
|
56
|
Screening for gestational diabetes.
|
Diabetes Care
|
1999
|
0.75
|
|
57
|
Depot medroxyprogesterone and bone density.
|
BMJ
|
1994
|
0.75
|
|
58
|
End stage diabetic renal disease in Polynesians in New Zealand.
|
N Z Med J
|
1990
|
0.75
|
|
59
|
Alternative medicine recommendations to patients with type 2 diabetes visiting health product shops and pharmacies.
|
Diabet Med
|
2002
|
0.75
|
|
60
|
Agreement between old and new diagnostic criteria in postpartum testing of women with gestational diabetes.
|
Diabetes Care
|
1998
|
0.75
|
|
61
|
Hyperparathyroid bone disease in chronic renal failure.
|
Ulster Med J
|
1985
|
0.75
|
|
62
|
Insulin-treated diabetes and driving in the UK.
|
Diabet Med
|
2003
|
0.75
|
|
63
|
The use of metabolites and analogues of vitamin D in prospective renal transplant recipients.
|
Clin Nephrol
|
1981
|
0.75
|
|
64
|
Pathogenesis of osteomalacia in chronic renal failure and its relationship to vitamin D.
|
Ann Med Interne (Paris)
|
1986
|
0.75
|
|
65
|
Late-onset type 1 diabetes in Pāsifika migrants living in Auckland.
|
Intern Med J
|
2014
|
0.75
|
|
66
|
Alcoholic ketoacidosis mimicking diabetic ketoacidosis.
|
N Z Med J
|
1992
|
0.75
|
|
67
|
Osteomalacia in renal disease.
|
Lancet
|
1980
|
0.75
|
|
68
|
Rapid suppression of plasma alkaline phosphatase activity after renal transplantation in patients with osteodystrophy.
|
Clin Chim Acta
|
1987
|
0.75
|
|
69
|
Serum thyrotrophin in patients with destructive pituitary lesions assessed by a sensitive immunoradiometric assay.
|
Ann Clin Biochem
|
1987
|
0.75
|
|
70
|
A comparison of oral and intravenous alfacalcidol in the treatment of uremic hyperparathyroidism.
|
J Am Soc Nephrol
|
1994
|
0.75
|
|
71
|
Severe vitamin D deficiency in Auckland.
|
N Z Med J
|
1993
|
0.75
|
|
72
|
An evaluation of 1 alpha-hydroxy-and 1,25-dihydroxyvitamin D3 in the treatment of renal bone disease.
|
Contrib Nephrol
|
1980
|
0.75
|
|
73
|
1alpha-hydroxy derivatives of vitamin D3 and renal function.
|
Lancet
|
1978
|
0.75
|
|
74
|
The role of vitamin D metabolites in the osteomalacia of renal disease.
|
Curr Med Res Opin
|
1981
|
0.75
|
|
75
|
Comparative effects of alfacalcidol and parathyroidectomy with vitamin D in hyperparathyroid renal bone disease.
|
Q J Med
|
1986
|
0.75
|
|
76
|
Effects of splenectomy for hereditary spherocytosis on glycated haemoglobin in a woman with Type 2 diabetes.
|
Diabet Med
|
2009
|
0.75
|
|
77
|
Bisphosphonate space measurement and dosage requirement for intravenous clodronate treatment of Paget's disease.
|
Calcif Tissue Int
|
2001
|
0.75
|
|
78
|
Effects of 24,25-dihydroxy-vitamin D3 on its plasma level in man.
|
Metab Bone Dis Relat Res
|
1981
|
0.75
|
|
79
|
Bone metabolism in acute parathyroid crisis.
|
Clin Endocrinol (Oxf)
|
1985
|
0.75
|
|
80
|
Metabolic bone disease and fractures in male alcoholics: a pilot study.
|
Br J Addict
|
1985
|
0.75
|
|
81
|
Bromocriptine treatment of acromegaly following spontaneous conception.
|
Fertil Steril
|
1984
|
0.75
|
|
82
|
Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation.
|
Acta Endocrinol (Copenh)
|
1985
|
0.75
|
|
83
|
Alcohol and bone disease.
|
Br J Addict
|
1981
|
0.75
|
|
84
|
Vitamin A and hyperparathyroid bone disease in uremia.
|
Am J Clin Nutr
|
1983
|
0.75
|
|
85
|
Marxism today.
|
N Z Med J
|
1989
|
0.75
|
|
86
|
Renal function changes in diabetic nephropathy induced by bezafibrate.
|
Nephron
|
1996
|
0.75
|
|
87
|
Effect of vitamin D2 on the assay of 24,25-dihydroxyvitamin D3 in man.
|
Miner Electrolyte Metab
|
1982
|
0.75
|
|
88
|
Latest news on metabolic bone disease.
|
Practitioner
|
1986
|
0.75
|
|
89
|
Assessing glycaemic control in diabetes: relationships between fructosamine and HbA1C.
|
N Z Med J
|
1997
|
0.75
|
|
90
|
Short dialysis regimens.
|
Br Med J
|
1979
|
0.75
|
|
91
|
Biological activity of endogenous and exogenous calcitonin in patients with osteitis fibrosa and chronic renal failure.
|
Proc Eur Dial Transplant Assoc
|
1978
|
0.75
|